Skip to main content

Post-IPO Debt Life Science Companies

Explore 11 life science startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
11
Total Funding
$3.1B
Avg Funding
$285.7M
Cities
10

Export 11 Post-IPO Debt Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
South San Francisco, United States
$50.0M
raised

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$10.0M
raised

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$11.8M
raised

Juva Life brings a depth of knowledge in the science and medicinal effects of cannabis.

Jun 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$1.3B
raised

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada
$505K
raised

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 11 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Menlo Park, United States
$10.0M
raised

Forum Markets developing novel drugs for treating distinct inflammatory diseases.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$75.0M
raised

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

Mar 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$125.0M
raised

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

Feb 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Waltham, United States
$1.5B
raised

Accelerating science. Transforming health. Expanding human potential. This is Revvity.

Jan 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$535K
raised

Awakn Life Sciences is an ecosystem for psychedelic-based treatments.

Dec 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 11 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Malvern, United States
$60.0M
raised

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Nov 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Debt Life Science Startups?

Get verified founder emails, funding details, and company data for 11 post-ipo debt life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked